Gilgamesh Pharmaceuticals has announced the nomination of two lead clinical candidates for the treatment of debilitating neuropsychiatric disorders such as depression, anxiety, PTSD, and substance use disorders
Category Press Release
Published in Biospace
Companies Featured
GilgameshGilgamesh is a preclinical biotechnology company focused developing new chemical entities in the psychedelic space.